Cyclin D1b Is Aberrantly Regulated in Response to Therapeutic Challenge and Promotes Resistance to Estrogen Antagonists

Cyclin D1 is a key mediator of cell cycle progression that is aberrantly regulated in multiple cancers, especially in breast cancers. A number of studies have indicated that a polymorphism in a splice donor site in the cyclin D1 gene is associated with alternative splicing and the production of the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Wang, Ying, Dean, Jeffry L., Millar, Ewan K.A., Tran, Thai Hong, McNeil, Catriona M., Burd, Craig J., Henshall, Susan M., Utama, Fransiscus E., Witkiewicz, Agnieszka, Rui, Hallgeir, Sutherland, Robert L., Knudsen, Karen E., Knudsen, Erik S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220573/
https://ncbi.nlm.nih.gov/pubmed/18632615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-07-3170
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados